These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31271049)

  • 1. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
    Mersfelder TL; Shiltz DL
    Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardioselective beta-blockers for chronic obstructive pulmonary disease.
    Salpeter SS; Ormiston T; Salpeter E; Poole P; Cates C
    Cochrane Database Syst Rev; 2002; (2):CD003566. PubMed ID: 12076486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioselective beta-blocker use in patients with reversible airway disease.
    Salpeter S; Ormiston T; Salpeter E
    Cochrane Database Syst Rev; 2001; 2002(2):CD002992. PubMed ID: 11406056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.
    Salpeter SR; Ormiston TM; Salpeter EE; Poole PJ; Cates CJ
    Respir Med; 2003 Oct; 97(10):1094-101. PubMed ID: 14561016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioselective beta-blockers for reversible airway disease.
    Salpeter S; Ormiston T; Salpeter E
    Cochrane Database Syst Rev; 2002; (1):CD002992. PubMed ID: 11869646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
    Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioselective beta-blockers for chronic obstructive pulmonary disease.
    Salpeter S; Ormiston T; Salpeter E
    Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD003566. PubMed ID: 16235327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commencement of cardioselective beta-blockers during hospitalisation for acute exacerbations of chronic obstructive pulmonary disease.
    Neef PA; Burrell LM; McDonald CF; Irving LB; Johnson DF; Steinfort DP
    Intern Med J; 2017 Sep; 47(9):1043-1050. PubMed ID: 28608512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations.
    Farland MZ; Peters CJ; Williams JD; Bielak KM; Heidel RE; Ray SM
    Ann Pharmacother; 2013 May; 47(5):651-6. PubMed ID: 23585645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis.
    Yang YL; Xiang ZJ; Yang JH; Wang WJ; Xu ZC; Xiang RL
    Eur Heart J; 2020 Dec; 41(46):4415-4422. PubMed ID: 33211823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioselective beta-blockers for reversible airway disease.
    Salpeter S; Ormiston T; Salpeter E
    Cochrane Database Syst Rev; 2002; (4):CD002992. PubMed ID: 12519582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of beta-blocker therapy on clinical outcomes, safety, health-related quality of life and functional capacity in patients with chronic obstructive pulmonary disease (COPD): a protocol for a systematic literature review and meta-analysis with multiple treatment comparison.
    Gulea C; Zakeri R; Quint JK
    BMJ Open; 2018 Nov; 8(11):e024736. PubMed ID: 30429149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease.
    Oda N; Miyahara N; Ichikawa H; Tanimoto Y; Kajimoto K; Sakugawa M; Kawai H; Taniguchi A; Morichika D; Tanimoto M; Kanehiro A; Kiura K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1119-1124. PubMed ID: 28435245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT.
    Dransfield MT; McAllister DA; Anderson JA; Brook RD; Calverley PMA; Celli BR; Crim C; Gallot N; Martinez FJ; Scanlon PD; Yates J; Vestbo J; Newby DE;
    Ann Am Thorac Soc; 2018 May; 15(5):608-614. PubMed ID: 29406772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cardioselective β-blockers in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized, placebo-controlled, blinded trials.
    Ni Y; Shi G; Wan H
    J Int Med Res; 2012; 40(6):2051-65. PubMed ID: 23321161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE) - Study protocol from a randomized controlled trial.
    Sundh J; Magnuson A; Montgomery S; Andell P; Rindler G; Fröbert O;
    Trials; 2020 Jan; 21(1):123. PubMed ID: 32000825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol.
    Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT
    BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
    Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
    Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of beta-blockers in the management of chronic obstructive pulmonary disease.
    Leitao Filho FS; Alotaibi NM; Yamasaki K; Ngan DA; Sin DD
    Expert Rev Respir Med; 2018 Feb; 12(2):125-135. PubMed ID: 29258360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.